NCT02944201 Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate Status UNKNOWN Phase PHASE2
NCT02936258 PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures Status UNKNOWN Phase NA
NCT02935816 Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques Status UNKNOWN Phase N/A
NCT02933801 ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. Status TERMINATED Phase PHASE2
NCT02933255 PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02928692 Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium Status UNKNOWN Phase PHASE3
NCT02928432 SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone Status COMPLETED Phase PHASE2
NCT02923180 Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02920229 68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated Status COMPLETED Phase NA
NCT02919111 Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients Status COMPLETED Phase PHASE2/PHASE3
NCT02918968 Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE4
NCT02918357 Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence Status COMPLETED Phase PHASE2/PHASE3
NCT02917798 Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02917161 Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study Status COMPLETED Phase NA
NCT02916537 A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057 Status COMPLETED Phase PHASE1
NCT02914873 SPCG17: Prostate Cancer Active Surveillance Trigger Trial Status ACTIVE_NOT_RECRUITING Phase NA
NCT02913859 Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer Status UNKNOWN Phase PHASE2